Jeff E. Knight

Companies

• ALX ONCOLOGY HOLDINGS INCChief Dev & Operating Officer Apr 17, 2026 to now¹
• Crinetics PharmaceuticalsChief Dev. & Operating Officer Apr 10, 2026 to now²
• Crinetics PharmaceuticalsChief operating officer Sep 2, 2021 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Crinetics Pharmaceuticals105,289 shares⁴Apr 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 8, 2026Sold 85,163 shares at $40.10 of Crinetics Pharmaceuticals⁴
• Apr 8, 2026Exercised options 19,336 shares at $19.64 of Crinetics Pharmaceuticals⁴
• Apr 8, 2026Exercised options 9,624 shares at $20.02 of Crinetics Pharmaceuticals⁴
• Apr 8, 2026Exercised options 49,474 shares at $23.98 of Crinetics Pharmaceuticals⁴
• Mar 16, 2026Sold 3,961 shares at $37.77 of Crinetics Pharmaceuticals⁵
• Mar 16, 2026Sold 5,950 shares at $37.11 of Crinetics Pharmaceuticals⁵
• Feb 23, 2026Granted 34,000 shares of Crinetics Pharmaceuticals⁶
• Mar 19, 2025Sold 361 shares at $34.83 of Crinetics Pharmaceuticals⁷
• Mar 19, 2025Sold 6,801 shares at $34.17 of Crinetics Pharmaceuticals⁷
• Feb 20, 2025Granted 43,000 shares of Crinetics Pharmaceuticals⁸
• Nov 22, 2024Sold 501 shares at $56.52 of Crinetics Pharmaceuticals⁹
• Jul 15, 2024Sold 27,000 shares at $55.00 of Crinetics Pharmaceuticals¹⁰
• Jul 15, 2024Exercised options 5,687 shares at $19.64 of Crinetics Pharmaceuticals¹⁰
• Jul 15, 2024Exercised options 2,887 shares at $20.02 of Crinetics Pharmaceuticals¹⁰
• Jul 15, 2024Exercised options 17,499 shares at $23.98 of Crinetics Pharmaceuticals¹⁰
• Jun 26, 2024Sold 956 shares at $44.38 of Crinetics Pharmaceuticals¹¹
• Mar 22, 2024Sold 2,359 shares at $45.39 of Crinetics Pharmaceuticals¹²
• Mar 22, 2024Sold 30,000 shares at $44.22 of Crinetics Pharmaceuticals¹²
• Mar 22, 2024Exercised options 30,000 shares at $23.98 of Crinetics Pharmaceuticals¹²
• Mar 18, 2024Shares withheld for tax 4,283 shares at $38.14 of Crinetics Pharmaceuticals¹³
• Mar 4, 2024Granted 23,000 shares of Crinetics Pharmaceuticals¹⁴
• Nov 20, 2023Other 931 shares at $14.98 of Crinetics Pharmaceuticals¹⁵
• May 22, 2023Other 891 shares at $14.98 of Crinetics Pharmaceuticals¹⁵
• Mar 16, 2023Shares withheld for tax 587 shares at $17.12 of Crinetics Pharmaceuticals¹⁶
• Mar 1, 2023Granted 29,500 shares of Crinetics Pharmaceuticals¹⁷